STOCK TITAN

[Form 3] Identive, Inc. Initial Statement of Beneficial Ownership

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3
Rhea-AI Filing Summary

Colony Bankcorp Inc. (CBAN) Form 4 highlights: Director Matthew D. Reed reported the grant of 969 restricted shares on 07/15/2025. Following the award, he now directly owns 16,736 common shares, up roughly 6% from the pre-grant level (~15,767). In addition, Reed holds 448 shares indirectly through an IRA for Kennedy K. Reed. No derivative securities, sales, or open-market purchases were disclosed.

The filing reflects a routine equity-based compensation grant and modestly increases insider ownership, which can align director incentives with shareholder interests. However, because the shares were granted (not purchased with personal funds), the transaction’s immediate signaling value is limited. No other material events, financial metrics, or changes to ownership structure were reported.

Colony Bankcorp Inc. (CBAN) Form 4 in evidenza: Il direttore Matthew D. Reed ha dichiarato la concessione di 969 azioni vincolate il 15/07/2025. A seguito di questo premio, detiene ora direttamente 16.736 azioni ordinarie, con un aumento di circa il 6% rispetto al livello precedente (~15.767). Inoltre, Reed possiede 448 azioni indirettamente tramite un IRA per Kennedy K. Reed. Non sono state segnalate operazioni su strumenti derivati, vendite o acquisti sul mercato aperto.

La comunicazione riflette una normale concessione di compensi basati su azioni e aumenta modestamente la partecipazione interna, allineando potenzialmente gli incentivi del direttore con gli interessi degli azionisti. Tuttavia, poiché le azioni sono state assegnate (e non acquistate con fondi personali), il valore informativo immediato della transazione è limitato. Non sono stati riportati altri eventi significativi, indicatori finanziari o variazioni nella struttura proprietaria.

Aspectos destacados del Formulario 4 de Colony Bankcorp Inc. (CBAN): El director Matthew D. Reed informó la concesión de 969 acciones restringidas el 15/07/2025. Tras esta adjudicación, ahora posee directamente 16,736 acciones ordinarias, un aumento de aproximadamente el 6% respecto al nivel previo (~15,767). Además, Reed tiene 448 acciones indirectamente a través de una IRA para Kennedy K. Reed. No se divulgaron valores derivados, ventas ni compras en el mercado abierto.

La presentación refleja una concesión rutinaria de compensación basada en acciones y aumenta modestamente la propiedad interna, lo que puede alinear los incentivos del director con los intereses de los accionistas. Sin embargo, dado que las acciones fueron concedidas (no compradas con fondos personales), el valor informativo inmediato de la transacción es limitado. No se reportaron otros eventos materiales, métricas financieras ni cambios en la estructura de propiedad.

Colony Bankcorp Inc. (CBAN) Form 4 주요 내용: 이사 Matthew D. Reed는 2025년 7월 15일에 969주의 제한 주식 부여를 보고했습니다. 이 수여 이후 그는 현재 직접 16,736주의 보통주를 보유하고 있으며, 이는 수여 전 약 6%(약 15,767주) 증가한 수치입니다. 또한 Reed는 Kennedy K. Reed를 위한 IRA를 통해 간접적으로 448주를 보유하고 있습니다. 파생 증권, 매도 또는 공개 시장 매수는 보고되지 않았습니다.

이번 신고는 일반적인 주식 기반 보상 부여를 반영하며 내부자 지분을 소폭 증가시켜 이사의 인센티브를 주주 이익과 일치시킬 수 있습니다. 다만, 주식이 개인 자금으로 구매된 것이 아니라 부여된 것이므로 거래의 즉각적인 신호 가치는 제한적입니다. 기타 중요한 사건, 재무 지표 또는 소유 구조 변경은 보고되지 않았습니다.

Points clés du Formulaire 4 de Colony Bankcorp Inc. (CBAN) : Le directeur Matthew D. Reed a déclaré la cession de 969 actions restreintes le 15/07/2025. Suite à cette attribution, il détient désormais directement 16 736 actions ordinaires, soit une augmentation d'environ 6 % par rapport au niveau précédent (~15 767). De plus, Reed détient 448 actions indirectement via un IRA pour Kennedy K. Reed. Aucune sécurité dérivée, vente ou achat sur le marché ouvert n’a été divulguée.

Le dépôt reflète une attribution de rémunération en actions de routine et augmente modestement la détention d’initiés, ce qui peut aligner les incitations du directeur avec les intérêts des actionnaires. Cependant, comme les actions ont été attribuées (et non achetées avec des fonds personnels), la valeur informative immédiate de la transaction est limitée. Aucun autre événement important, indicateur financier ou changement dans la structure de propriété n’a été signalé.

Colony Bankcorp Inc. (CBAN) Form 4 Highlights: Direktor Matthew D. Reed meldete die Gewährung von 969 eingeschränkten Aktien am 15.07.2025. Nach der Zuteilung besitzt er nun direkt 16.736 Stammaktien, was einem Anstieg von etwa 6 % gegenüber dem vorherigen Bestand (~15.767) entspricht. Zusätzlich hält Reed 448 Aktien indirekt über ein IRA für Kennedy K. Reed. Es wurden keine Derivate, Verkäufe oder Käufe am offenen Markt gemeldet.

Die Meldung spiegelt eine routinemäßige aktienbasierte Vergütung wider und erhöht den Insiderbesitz leicht, was die Interessen des Direktors mit denen der Aktionäre in Einklang bringen kann. Da die Aktien jedoch gewährt wurden (nicht mit eigenen Mitteln gekauft), ist der unmittelbare Signalwert der Transaktion begrenzt. Es wurden keine weiteren wesentlichen Ereignisse, Finanzkennzahlen oder Änderungen in der Eigentümerstruktur gemeldet.

Positive
  • Director ownership rises ~6%, marginally improving management-shareholder alignment
Negative
  • None.

Insights

TL;DR: Routine restricted-stock grant lifts director’s stake 6%; alignment positive but signal limited versus open-market buy.

Restricted stock awards are standard board compensation. Reed’s direct ownership rises to 16,736 shares, keeping directors’ interests aligned with investors. Because no cash outlay was made, market shouldn’t infer the same confidence as an outright purchase. No red flags—no sales, pledges, or derivative positions—so governance risk remains low. Impact: neutral-positive.

TL;DR: Small, non-cash insider acquisition; negligible valuation impact.

The 969-share grant equates to <1% of CBAN’s ~9.0 m shares outstanding, therefore immaterial to float or supply/demand. Because the stock was awarded, not bought, it doesn’t convey incremental bullish sentiment. I view the event as routine and non-impactful for portfolio positioning.

Colony Bankcorp Inc. (CBAN) Form 4 in evidenza: Il direttore Matthew D. Reed ha dichiarato la concessione di 969 azioni vincolate il 15/07/2025. A seguito di questo premio, detiene ora direttamente 16.736 azioni ordinarie, con un aumento di circa il 6% rispetto al livello precedente (~15.767). Inoltre, Reed possiede 448 azioni indirettamente tramite un IRA per Kennedy K. Reed. Non sono state segnalate operazioni su strumenti derivati, vendite o acquisti sul mercato aperto.

La comunicazione riflette una normale concessione di compensi basati su azioni e aumenta modestamente la partecipazione interna, allineando potenzialmente gli incentivi del direttore con gli interessi degli azionisti. Tuttavia, poiché le azioni sono state assegnate (e non acquistate con fondi personali), il valore informativo immediato della transazione è limitato. Non sono stati riportati altri eventi significativi, indicatori finanziari o variazioni nella struttura proprietaria.

Aspectos destacados del Formulario 4 de Colony Bankcorp Inc. (CBAN): El director Matthew D. Reed informó la concesión de 969 acciones restringidas el 15/07/2025. Tras esta adjudicación, ahora posee directamente 16,736 acciones ordinarias, un aumento de aproximadamente el 6% respecto al nivel previo (~15,767). Además, Reed tiene 448 acciones indirectamente a través de una IRA para Kennedy K. Reed. No se divulgaron valores derivados, ventas ni compras en el mercado abierto.

La presentación refleja una concesión rutinaria de compensación basada en acciones y aumenta modestamente la propiedad interna, lo que puede alinear los incentivos del director con los intereses de los accionistas. Sin embargo, dado que las acciones fueron concedidas (no compradas con fondos personales), el valor informativo inmediato de la transacción es limitado. No se reportaron otros eventos materiales, métricas financieras ni cambios en la estructura de propiedad.

Colony Bankcorp Inc. (CBAN) Form 4 주요 내용: 이사 Matthew D. Reed는 2025년 7월 15일에 969주의 제한 주식 부여를 보고했습니다. 이 수여 이후 그는 현재 직접 16,736주의 보통주를 보유하고 있으며, 이는 수여 전 약 6%(약 15,767주) 증가한 수치입니다. 또한 Reed는 Kennedy K. Reed를 위한 IRA를 통해 간접적으로 448주를 보유하고 있습니다. 파생 증권, 매도 또는 공개 시장 매수는 보고되지 않았습니다.

이번 신고는 일반적인 주식 기반 보상 부여를 반영하며 내부자 지분을 소폭 증가시켜 이사의 인센티브를 주주 이익과 일치시킬 수 있습니다. 다만, 주식이 개인 자금으로 구매된 것이 아니라 부여된 것이므로 거래의 즉각적인 신호 가치는 제한적입니다. 기타 중요한 사건, 재무 지표 또는 소유 구조 변경은 보고되지 않았습니다.

Points clés du Formulaire 4 de Colony Bankcorp Inc. (CBAN) : Le directeur Matthew D. Reed a déclaré la cession de 969 actions restreintes le 15/07/2025. Suite à cette attribution, il détient désormais directement 16 736 actions ordinaires, soit une augmentation d'environ 6 % par rapport au niveau précédent (~15 767). De plus, Reed détient 448 actions indirectement via un IRA pour Kennedy K. Reed. Aucune sécurité dérivée, vente ou achat sur le marché ouvert n’a été divulguée.

Le dépôt reflète une attribution de rémunération en actions de routine et augmente modestement la détention d’initiés, ce qui peut aligner les incitations du directeur avec les intérêts des actionnaires. Cependant, comme les actions ont été attribuées (et non achetées avec des fonds personnels), la valeur informative immédiate de la transaction est limitée. Aucun autre événement important, indicateur financier ou changement dans la structure de propriété n’a été signalé.

Colony Bankcorp Inc. (CBAN) Form 4 Highlights: Direktor Matthew D. Reed meldete die Gewährung von 969 eingeschränkten Aktien am 15.07.2025. Nach der Zuteilung besitzt er nun direkt 16.736 Stammaktien, was einem Anstieg von etwa 6 % gegenüber dem vorherigen Bestand (~15.767) entspricht. Zusätzlich hält Reed 448 Aktien indirekt über ein IRA für Kennedy K. Reed. Es wurden keine Derivate, Verkäufe oder Käufe am offenen Markt gemeldet.

Die Meldung spiegelt eine routinemäßige aktienbasierte Vergütung wider und erhöht den Insiderbesitz leicht, was die Interessen des Direktors mit denen der Aktionäre in Einklang bringen kann. Da die Aktien jedoch gewährt wurden (nicht mit eigenen Mitteln gekauft), ist der unmittelbare Signalwert der Transaktion begrenzt. Es wurden keine weiteren wesentlichen Ereignisse, Finanzkennzahlen oder Änderungen in der Eigentümerstruktur gemeldet.

SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
KIRNBAUER EDWARD

(Last) (First) (Middle)
1900-B CARNEGIE AVENUE

(Street)
SANTA ANA CA 92705

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
07/11/2025
3. Issuer Name and Ticker or Trading Symbol
Identiv, Inc. [ INVE ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
See Remarks
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 55,561(1) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Includes 25,594 shares of common stock issuable pursuant to restricted stock units that have not vested.
Remarks:
Acting Chief Financial Officer and Secretary; Exhibit List: Exhibit 24 - Power of Attorney
/s/ Edward Kirnbauer 07/17/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many CBAN shares did Director Matthew D. Reed acquire?

He received 969 restricted shares on 07/15/2025.

What is Reed’s total direct ownership after the transaction?

He now directly holds 16,736 CBAN common shares.

Were any CBAN shares sold in this Form 4?

No. The filing only reports an acquisition; there were no dispositions.

Does the filing include derivative securities or options?

No derivative securities were reported; the table for derivatives is blank.

Is the acquisition an open-market purchase?

No, it is a restricted stock award grant, part of board compensation.
Identiv

NASDAQ:INVE

INVE Rankings

INVE Latest News

INVE Latest SEC Filings

INVE Stock Data

85.02M
20.27M
12.48%
54.69%
0.54%
Building Products & Equipment
Computer Peripheral Equipment, Nec
Link
United States
SANTA ANA